Recordati S.p.A

127 articles about Recordati S.p.A

• Recordati S.p.A Buys Poland's Farma-Projekt for 17.3 Million Euros

  8/3/2012

• Recordati S.p.A: Positive First Half 2012 Results (Revenue +4.7%, Net Income +1.5%)

  7/26/2012

• Recordati S.p.A: Good First Quarter 2012 Results (Revenue +11.0%, Net Income +7.5%)

  5/8/2012

• Recordati S.p.A Acquires Six OTC Products in Germany

  4/24/2012

• Recordati S.p.A: Board Approves the 2011 Accounts

  3/7/2012

• Recordati S.p.A and Nymox Pharmaceutical Announce the Start of European Phase III Clinical Trial for NX-1207

  2/21/2012

• Recordati S.p.A and Nymox Pharmaceutical Announce the Start of European Phase III Clinical Trial for NX-1207

  2/21/2012

• Recordati S.p.A: Positive Preliminary 2011 Results; Sales +4.7%, EBIT +5.6%, Net Income +7.2%

  2/9/2012

• Recordati S.p.A: Board of Directors Approves 2011 Interim Dividend of EUR 0.20 Per Share

  11/15/2011

• Recordati S.p.A: Very Good First 9 Months 2011 Results; Sales +5.8%; Net Income +5.8%; Interim Dividend Policy Approved

  10/25/2011

• Recordati S.p.A Finalizes its Acquisition of Frik Ilac in Turkey

  9/15/2011

• Recordati S.p.A: Very Good First Half 2011 Results. Sales +6.6%. Net Income +5.3%

  7/26/2011

• Recordati S.p.A Acquires Dr. Frik Ilac; in Turkey

  7/6/2011

• Orphan Europe Recordati S.p.A Receives 2011 Corporate Award From the National Organization for Rare Disorders (NORD)

  5/18/2011

• Recordati S.p.A Sales and Income Increase in the First Quarter 2011; 3 Year Business Plan Updated

  5/6/2011

• Recordati S.p.A: Shareholders Approve the 2010 Accounts; Dividend EUR 0.275 Per Share

  4/13/2011

• Recordati S.p.A to Participate at The Italian Investor Conference in New York and in Toronto

  3/15/2011

• Recordati S.p.A Release: Preliminary Full Year 2010 Results: Revenues Eur 728.1 M., Net Income Eur 108.6 M. Profitability Margins in Line with 2009

  2/9/2011

• Recordati S.p.A Acquires Procto-Glyvenol(R) for the Central and Eastern European Markets

  1/19/2011

• Recordati S.p.A Signs Co-Marketing Agreement With Merck Serono in France for Pitavastatin

  12/27/2010